London, United Kingdom

Tamara Nicolson

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • London, GB (2018 - 2024)
  • Oxfordshire, GB (2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tamara Nicolson

Introduction

Tamara Nicolson is a distinguished inventor based in London, GB. With a remarkable portfolio of six patents, she has made significant contributions to the field of biotechnology, particularly in the treatment of hyperammonemia. Her innovative work highlights the potential of protein therapies in addressing complex medical challenges.

Latest Patents

Among Nicolson's latest inventions is a novel approach to treating hyperammonemia through the use of glutamine synthetase. This invention focuses on utilizing glutamine synthetase as a protein therapy, specifically in enzyme replacement therapy. Notably, her work emphasizes the systemic administration of glutamine synthetase, enhancing its efficacy by providing it in conjugated or fusion form to extend its half-life in circulation. Furthermore, she has developed pharmaceutical compositions that combine glutamine synthetase with ammonia-lowering agents, such as nitrogen scavengers, to improve treatment outcomes for patients suffering from this condition.

Career Highlights

Throughout her career, Tamara Nicolson has collaborated with notable organizations in the biotechnology sector. She has served at Psioxus Therapeutics Limited, where she contributed to groundbreaking research and development projects. Additionally, her tenure at Thoeris GmbH allowed her to further her expertise and impact within the industry.

Collaborations

Tamara has worked alongside talented individuals such as Alice Claire Noel Brown and Brian Robert Champion. These collaborations have fostered an environment of innovative thinking and problem-solving, leading to significant advancements in their respective fields.

Conclusion

Tamara Nicolson's work exemplifies the spirit of innovation within the biotechnology industry. Her contributions, particularly in utilizing glutamine synthetase for therapeutic purposes, highlight her role as a leading inventor. With her ongoing endeavors, Nicolson continues to pave the way for future breakthroughs in medical science, contributing to improved healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…